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Abstract
Background: The first survey on sickle cell disease (SCD) done in Uganda in 1949, reported the district of Bundibugyo 
in Western Uganda to have the highest sickle cell trait (SCT) prevalence (45%). This is believed to be the highest in the 
whole world. According to the same survey, the prevalence of SCT in the districts of Mbale and Sironko in the East was 
20-28%, whilst the districts of Mbarara and Ntungamo in the West had 1-5%. No follow-up surveys have been 
conducted over the past 60 years. SCA accounts for approximately 16.2% of all pediatric deaths in Uganda. The pattern 
of SCT inheritance, however, predicts likely changes in the prevalence and distribution of the SCT. The objective of the 
study therefore was to establish the current prevalence of the SCT in Uganda.
Methods: This study was a cross sectional survey which was carried out in the districts of Mbale and Sironko in the 
Eastern, Mbarara/Ntungamo and Bundibugyo in Western Uganda. The participants were children (6 months-5 yrs). 
Blood was collected from each subject and analyzed for hemoglobin S using cellulose acetate Hb electrophoresis.
Results: The established prevalence of the SCT (As) in Eastern Uganda was 17.5% compared to 13.4% and 3% in 
Bundibugyo and Mbarara/Ntungamo respectively. 1.7% of the children in Eastern Uganda tested positive for 
haemoglobin ss relative to 3% in Bundibugyo, giving gene frequencies of 0.105 and 0.097 for the recessive gene 
respectively. No ss was detected in Mbarara/Ntungamo.
Conclusions: A shift in the prevalence of the SCT and ss in Uganda is notable and may be explained by several 
biological and social factors. This study offers some evidence for the possible outcome of intermarriages in reducing 
the incidence of the SCT.
Background
Sickle cell disease is an inherited hemoglobinopathy aris-
ing from the substitution of glutamic amino acid by
valine in the sixth position of the beta globin chain [1].
Inheritance of the sickle cell trait follows a recessive auto-
somal pattern. Phenotypically, only persons with double
recessive genes of sickle cell (ss homozygotes) do mani-
fest disease, whilst the heterozygotes (AS) are being
referred to as carriers. According to Diallo, Africa is the
most highly affected continent with 200,000 new born
affected by sickle cell anemia (SCA) per year [1]. This
constitutes approximately 66.6% of the children born
with haemoglobinopathies worldwide. According to
reports from Ghana, it is estimated that 15,000 children
are born with sickle cell disease (SCD) annually [2]. In
Benin, the sickle cell trait (SCT) prevalence is estimated
to be 25% [3] while in Nigeria it ranges from 24-25% [4,5].
The prevalence of the sickle cell gene among the Chagga
tribe in Tanzania on the other hand is about 4%. In all
these African countries, the concentration of the SCT has
been found to be highest in specified sub-populations [1-
5], likely due to tribal conservative marriages. The auto-
somal recessive pattern of inheritance assumed by SCT,
however, predicts changes in population-wide dynamics,
ease of movement and inter-tribal marriages which
would alter the SCT distribution within these communi-
ties [6].
The available data on the population-wide prevalence
of SCD in Uganda is based on a survey by Lehmann and
Raper in 1949 [7]. According to the same, the prevalence
of SCT among Ugandan tribes, ranged from 4 to 45%, and
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was reported to be the highest among the Baamba in the
West where malaria is endemic [7]. Of the 900,000 thou-
sand children born annually in Uganda [8], approximately
2.8% have sickle cell anemia (ss homozygotes) [9]. A stag-
gering 20,000 (70-80%) of these children born with SCA
presumably die before their 5th birth day. This number
contributes 16.2% of all children (123,000) who die annu-
ally in Uganda [10].
In light of the advances in care interventions, pre-mari-
tal genome-wide population screening and counseling, it
is supposed that the distribution of the SCT among Afri-
can populations may be strategically altered. However,
evidence for positive outcome of intermarriage in reduc-
ing the incidence of the SCT needs to be established. We
hypothesized that, a current survey of the prevalence of
sickle cell disease in Uganda, when related to prior find-
ings by Lehmann and Raper [7], will be informative of the
same. This study was therefore conducted to ascertain an
up-date on the prevalence of sickle cell trait in Eastern
and Western Uganda.
Methods
Study design
This was a cross sectional survey.
Study populations and sites
We studied populations in five districts: Sironko and
Mbale in Eastern; Mbarara, Ntungamo and Bundibugyo
in Western Uganda (See figure 1 for a map of Uganda and
location of the study districts). The district of Bundibu-
gyo was selected because of its uniqueness in that it is
believed to have the highest prevalence (45%) of sickle
cell trait in the world [7].
Study subjects
These were children aged between 6 months and 5 years.
The sample size of 571 was calculated using Kish and
Leshlie formula [11]. The prevalence of 23.8% was used
for eastern, 5% for Mbarara/Ntungamo and 45% for
Bundibugyo in W estern Uganda as established by Leh-
man. The precisions of 5% and 2.5% were used for East-
ern and Mbarara and Ntungamo respectively, while a
precision of 7% was taken for Bundibugyo. A confidence
interval of 95% was used. Through-out the recruitment,
selection of participating children was done randomly,
using a register of populations at the local council I level.
Specifically, serial recruitment was done using odd num-
bers viz: 1, 3, 5, 7...,13,15.
This study was approved by the Makerere University
College of Health Sciences (formerly faculty of Medicine)
Research and Ethics Committee. For all the participating
children, a written informed consent was obtained from
legal authority (guardian or parent).
Sample collection
A maximum of 2 mls of blood sample was collected in
ethylene diamine tetra acetic acid (EDTA) vacutainers
from either a hand vein or by heel puncture from each
infant at health centers and nursery schools. Samples
were delivered in ice boxes to Mulago hospital for analy-
sis using Hb electrophoresis at pH 9.2 on cellulose acetate
strips [12]. Hb electrophoretic bands were then stained
and compared with the known controls.
• Between March and August 2007, a total of 656 
blood samples were collected from 656 randomized 
children in Male and Sironko in Eastern; and Mbarara 
and Ntungamo in the West which was a little (1.1%) 
more than the minimum calculated sample size of 
571. A total of 286 and 370 children participated in 
the study from Eastern and Western respectively.
• From June to July 2009, a total of 201 blood samples 
were collected from 201 children in Bundibugyo dis-
trict in Western Uganda which was (1.0%) more than 
the calculated sample size of 194
Data analysis
The data was entered and analyzed by using statistical
package for social sciences (SPSS 10.0) SPSS Advanced
Statistics 10.1. Chicago: SPSS Inc, 2000). The gene fre-
quency was calculated using the Hardy Weinberg Law
[13]. The statistical difference of the prevalence of SCT
and SS in these study populations was compared using
Open Source Epidemiologic Statistic Program for Public
Health version 2.2.1 (OPENEPI) using 2 × 2 contingency
tables [14]. A p value of ≤0.05 was considered statistically
significant.
Results
In Mbale and Sironko districts, 231 children (80.8%) were
positive for Hb AA, 50 (17.5%) for Hb AS and 5 (1.7%) for
SS, while Mbarara and Ntungamo districts had 359 chil-
dren positive for Hb AA (97%), 11 for Hb AS (3%) and
none had SS. In Bundibugyo district, 168 were positive
for AA (83.6%), 27 for AS (13.4%) and 6 (3%) for SS (see
Table 1 and Figure 2).
In Eastern Uganda, with a heterozygous prevalence of
17.5% and homozygous prevalence of 1.7%, the total per-
centage of abnormal genes within the population was cal-
culated to be ([17.5/2 +1.7]) or simply 10.45%. This yields
a gene frequency of 0.105. The expected gene frequency
of the homozygotes in Eastern Uganda, given a gene fre-
quency of 0.105, would be (0.105) [2] or 1.1% In Western
Uganda (specifically Bundibugyo), at a heterozygous
prevalence of 13.4% and homozygous prevalence of 3%,
the total percentage of abnormal genes within the popu-
lation was ([13.4/2 +3]) or simply 9.7%. This yields a gene
frequency of 0.097. The expected gene frequency of theOkwi et al. BMC Blood Disorders 2010, 10:5
http://www.biomedcentral.com/1471-2326/10/5
Page 3 of 6
Figure 1 Map of Uganda, showing location of study districts. This map aims to orientate the reader in regard to locations of the major study dis-
tricts:Mbale and Sironko (East); and Mbarara/Ntungamo and Budibugyo (West).
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homozygotes in Bundibugyo, given a gene frequency of
0.097, would be (0.097) [2] or 0.94%.
As a notable finding, we observed that the statistical
difference in the prevalence of AS between Mbarara/
Ntungamo in the West and both Mbale/Sironko in the
East and Bundibugyo in the West was highly significant
(<0.001). There was however no statistical difference in
the prevalence of AS between Mbale/Sironko in the East
and Bundibugyo in the West (>0.05). The difference in
the prevalence of homozygous state (SS) of sickle cell dis-
ease between Bundibugyo in the West and Mbale/
Sironko in the East was statistically insignificant (>0.05).
The statistical differences in the prevalence of AS and SS
between the study districts is as shown in Table 2.
Discussion
Contrary to earlier report by Lehmann and Rapper [7],
our results show that, the prevalence of the AS carrier
state was highest in Eastern Uganda, followed by
Bundibugyo (see Figure 1-map of Uganda, and Figure 2
for distribution of results). The fact that the first survey
on sickle cell disease (SCD) in Uganda was done over 60
years ago, and no similar surveys have been conducted
since then; it is not surprising that SCD has changed its
dynamics. This is because the inherited nature of the
SCD trait predicts likely changes in the prevalence and
distribution of the same depending on the prevailing bio-
logical (malaria interventions) and social factors (mar-
riage patterns). Indeed, contrary to an earlier report of
45% prevalence of the AS trait in Bundibugyo, we found
the current AS prevalence to be 13.4%; changes that we
have appropriated to the possible earlier adoption of
intermarriage-avoidance in Bundibugyo resulting from a
similarly earlier knowledge of AS prevalence [7]. Specifi-
cally, although the difference in the prevalence of AS
between Eastern Uganda and Bundibugyo in the west was
statistically insignificant, the prevalence of AS in
Bundibygyo (13.4%) was found to be much lower than
estimated by Lehmann and Raper (45%), see Tables 1 &2
for details. Several hypotheses may be used to explain this
finding. The same should, however, be cautiously
employed here since huge heterogeneity within the spa-
tial distribution of genetic factors have been found in
many studies (even over relatively very small areas) and
the small number of subjects sampled in our study makes
Table 1: Summary of the observed prevalence of AS and SS and expected prevalence of SS in eastern and western Uganda, 
2007.
Study area Observed prevalence of AS (%) Observed prevalence of SS (%) Expected prevalence of SS*
Mbale/Sironko (Eastern 
Uganda)
n = 286
17.5 1.75 4.20
[95% CI 13.5-22.3] [95% CI 0.63-4.15]
Mbarara/Ntungamo 
(Western Uganda)
N = 370
3.0 0.0 1.70
[95% CI 1.61-5.31] [95% CI 0.0-1.24]
Buundibugyo (Western 
Uganda)
N = 201
13.4 3 3.70
[95% CI 9.35-18.94] [95% CI 0.31-4.50]
* Expected prevalence of SS = square root of AS prevalence according to Mordell and Darlison [16].
Figure 2 The percentage of haemoglobin A, AS and SS detected 
in our study population. This data describes the percentage of hae-
moglobin A, AS and SS detected in our study population. The districts 
of Uganda represented are Mbale and Sironko (East); and Mbarara/
Ntungamo and Budibugyo (West).Okwi et al. BMC Blood Disorders 2010, 10:5
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such comparisons inaccurate. First, basing on the first
survey of 1949, which was 60 years ago, the Baamba was
one of the exclusively preserved tribes in Uganda which
practiced high level of consanguinity. However, due to the
movement of the people, the Baamba may have intermar-
ried into other tribes leading to sickle cell gene admixture
or dilution. Secondly, though it is possible that improved
malaria interventions may have selected for increased
numbers of haemoglobin AA and decreased numbers of
AS [15], it is unlikely, because the heterozygous HbAS
trait has been observed to have beneficial effects in pro-
tecting against severe forms P. falciparum infection. On
the other hand the prevalence of SCT in Mbale/Sironko
was slightly lower than the 20-28% estimated by Leh-
mann) and Rapper [7]. It is possible that due to improved
malaria intervention programmes in Uganda, some of the
people with AS may have been denied resistance against
malaria infection as already explained above.
A number of notable difference between our and Leh-
mann and Raper's study [7] are observable. For instance,
while our finding of 3% AS in Mbarara/Ntungamo was
similar to the 1-5% reported by Lehmann, it is clear that
the prevalence of AS in these districts had remained low.
The most likely reason for this observation was as cited
above. Improved malaria interventions could have denied
persons with AS protection against malaria thus keeping
their numbers low [15]. Secondly, it is possible that the
level of intermarriage between these communities and
other tribes could still be very low and as a result, emer-
gence of new cases of sickle cell disease due to gene
admixture may have been curtailed. On the other hand,
in as much as the prevalence of SCT in Bundibugyo was
lower than 45% reported by Lehmann, it is possible that
the prevalence of sickle cell trait among Baamba adult
population is still high. This hypothesis is supported by
the fact that the study found high prevalence of SS among
the children which could be reflective of a high preva-
lence of AS in the adult population. This finding is fur-
ther supported by the fact that our study sampled
children while Lehmann study sampled adults. The
observed prevalence of SS in all these districts was actu-
ally much lower than expected [16]. In absence of cost
effective screening interventions [17] and therapeutic
measures for sickle cell disease within this setting such as
bone marrow transplantation and gene therapy [18], the
obvious question to ask regards what may have happened
t o  t h e  m i s s i n g  S S  p r o g e n y .  I t  i s  po s s i b l e  t h a t  m a n y  o f
these children could have succumbed to the disease
before celebrating their fifth birthday because of the
absence of comprehensive sickle cell screening and man-
agement programmes in these districts. Serjeant and
Ndugwa alluded to this in their advocacy paper [9]. This
hypothesis appeared to have been supported by the fact
that all the children who were detected with SS in Mbale/
Sironko in Eastern and Bundibugyo in the West were less
than 4 years old; suggesting that ss cases are hardly
detectable at 5 years since many of these children could
possibly have died before their fifth birthday. This may
probably further explains why the data on median sur-
vival of persons with sickle cell anemia in many develop-
ing countries including Uganda is scarce. The fact that no
c h i l d r e n  w i t h  S S  w e r e  d e t e c t ed  i n  M b a r a r a / N t u n g a m o
does not mean that these children do not exist. The prob-
able reason for this observation was that the number of
AS persons may have been kept further low in these dis-
tricts by natural law of selection as new effective malaria
intervention progammes have been put in place This,
therefore, could have in turn kept the number of SS low
and therefore influencing the detectability of SS cases.
Another reason for this could be that the delectability
power (precision) used was probably not sensitive
enough such that, if this study was to be repeated today
using a more sensitive power, children with SS would
h a v e  b e e n  d e t e c t e d  i n  M b a r a r a / N t u n g a m o  a n d  m o r e
children with SS would have been detected in Bundibu-
gyo in the West and Mbale/Sironko in the East. Lastly,
there are several shortcomings in our study. First,
although we used Hb electrophoresis as our 'gold stan-
dard' because of its affordability and availability, better
gold standards such as automated capillary Hb electro-
phoresis are preferred. (Sebia Parc Technlonogique,
Leonard de Vinci. CP 8010 Lisses-91008. EVRY Cedex-
France). Secondly, in as much as the recruitment of the
study participants was randomized, the selection of the
Table 2: The statistical difference in the prevalence of AS and SS between the study districts.
Variable Mbale and Sironko Mbarara and Ntungamo Odds Ratio CI P-value
AS 50 (286) 11 (370) 6.91 3.53-13-13.6 0.001
Variable Mbale and Sironko Bundibugyo Odds Ratio CI P-value
AS 50 (286) 27 (201) 1.36 0.82-2.27 0.110
SS 5 (286) 6 (201) 0.58 0.17-1.92 0.193
Variable Bundibugyo Mbarara and Ntungamo Odds Ratio CI P-value
AS 27 (201) 11 (370) 5.06 2.46-10.45 0.001Okwi et al. BMC Blood Disorders 2010, 10:5
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study districts was based on convenience sampling and
did not therefore give equal chance to the rest of the dis-
tricts in Eastern and Western Uganda to be represented.
So the current results cannot be generalized as represen-
tative of the whole Eastern or Western Uganda. Thirdly,
as observed above (results section), the statistical differ-
ence in the prevalence of AS between Mbarara/
Ntungamo in the West and both Mbale/Sironko in the
East and Bundibugyo in the West was highly significant
(<0.001); and this may affect our study versus real figures
on ground.
Conclusion
Contrary to earlier reports, our study suggests the possi-
ble decline in the prevalence of the AS carrier state espe-
cially amongst the Baamba of western Uganda. This shift
might have resulted from several social (marriage pat-
terns) and possibly biological (malaria interventions) fac-
tors.
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